Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | $700.00K | $1.42M | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | $1.21M | $11.94M | $1.97M | $1.09M | $666.00K | $665.00K | $665.00K |
| Gross Profit | N/A | $-1.21M | $-11.24M | $-550.00K | $-1.09M | $-666.00K | $-665.00K | $-665.00K |
| Gross Margin | 0.00% | 0.00% | -1606.29% | -38.79% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Expenses | $56.26M | $42.37M | $46.81M | $62.46M | $48.87M | $47.29M | $37.30M | $25.15M |
| Operating Income | $-56.26M | $-43.57M | $-58.06M | $-63.01M | $-49.97M | $-47.95M | $-37.96M | $-25.81M |
| Operating Margin | 0.00% | 0.00% | -8293.86% | -4443.86% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income | $-53.59M | $-42.21M | $-58.51M | $-63.66M | $-49.74M | $-45.99M | $-37.55M | $-25.57M |
| Net Margin | 0.00% | 0.00% | -8357.86% | -4489.42% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS (Basic) | $-0.92 | $-0.88 | $-1.72 | $-2.28 | $-2.14 | $-2.22 | $-2.20 | $-1.73 |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |